References

Abbott Laboratories. “Meridia (sibutramine hydrochloride monohydrate) product information.” May 2002. www.rxabbott.com/pdf/meridia.pdf.

“Absorption and transportation of nutrients.” NutriStrategy (from National Institutes of Health National Institute of Diabetes and Digestive Kidney Diseases). 2001. www.nutristrategy.com/digestion.htm.

Abu Abeid S et al. “Treatment of intra gastric band migration following laparoscopic banding: safety and feasibility of simultaneous laparoscopic band removal and replacement.” Obes Surg. 2005; 15(6): 849–852.

Alpor CM. “Effects of chronic peanut consumption on energy balance and hedonics.” International Journal of Obesity. 2002; 26(8): 1,129–1,137.

Anderson RA. “Cinnamon, glucose tolerance and diabetes.” Agricultural Research Service. United States Department of Agriculture. November 17, 2006.

Anoja S et al. “Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component.” Diabetes. 2002; 51: 1,851–1,858.

Arnot R. Dr. Bob Arnot’s Revolutionary Weight Control Program. Little, Brown; 1997.

Astrup A et al. “Randomized controlled trials of the D1/D5 antagonist ecopipam for weight loss in obese subjects.” Obesity (Silver Spring). 2007; 15(7): 1,717–1,731.

Atkins RC. Dr. Atkins’ New Diet Revolution. Avon Books; 2002.

Backgrounder: why sleep matters. National Sleep Foundation. March 2002. www.sleepfoundation.org/nsaw/pk_background.html.

Balsiger BM et al. “Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity.” Journal of the American Medical Association. 1999; 282(16): 1,530–1,538.

Barclay L. “Topiramate useful for binge eating disorder in obesity.” American Journal of Psychiatry. 2003; 160: 255–261.

Barkeling B et al. “Short-term effects of sibutramine (Reductil) on appetite and eating behavior and the long-term therapeutic outcome.” International Journal of Obesity. 2003; 27(6): 693–700.

Batterham RL, Cohen MA, Ellis SM, Le Roux CR, Withers DJ, Frost GS, Ghatei M, Bloom SR. “Inhibition of food intake in obese subject by peptide YY3-36.” New England Journal of Medicine. 2003; 349: 941–948.

Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin C, Wren AM, Brynes A, Low M, Ghatei M, Cone R, Bloom SR. “Gut hormone PYY3-36 physiologically inhibits food intake.” Nature. 2002; 418: 650–654.

Behavior Risk Factor Surveillance System. Trends data, 2001. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Adult and Community Health. February 18, 2003. www.cdc.gov/brfss/index.htm.

Benzphetamine. RXlist.com. www.rxlist.com/frame/display.cgi?drug=DIDREX.

Blackburn GL, Bevis LC. “The obesity epidemic: prevention and treatment of the metabolic syndrome CME.” Medscape. www.medscape.com/viewprogram/2015_index.

Blankson H et al. “Conjugated linoleic acid reduces body fat mass in overweight and obese humans.” Journal of Nutrition. 2000; 130: 2,943–2,948.

BMI for Adults, Body Mass Index Formula. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Nutrition and Physical Activity. April 21, 2003. www.cdc.gov/nccdphp/dnpa/bmi/bmi-adult-formula.htm.

Body Mass Index (BMI) Table. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Nutrition and Physical Activity. April 21, 2003. www.cdc.gov/nccdphp/dnpa/bmi/00binaries/bmi-adults.pdf.

Bosch B et al. “Human chorionic gonadotrophin and weight loss. A double-blind, placebo-controlled trial.” S Afr Med J. February 17, 1990; 77(4): 185–189.

Boza C et al. “Laparoscopic adjustable gastric banding (LAGB): surgical results and 5-year follow-up.” Surg Endosc. July 22, 2010.

Brain M. “How food works.” HowStuffWorks.com. home.howstuffworks.com/food.htm/printable.

Bray GA et al. “A six-month randomized, placebo controlled, dose-ranging trial of topiramate for weight loss in obesity.” Obesity Research. 2003; 11: 722–733.

Brownstein D. The Miracle of Natural Hormones. Medical Alternative Press; 1999.

Brownstein D. Overcoming Arthritis. Medical Alternatives Press; 2001.

Brownstein D. Overcoming Thyroid Disorders. Medical Alternatives Press; 2002.

Brunova J et al. “Hyperthyroidism therapy and weight gain.” [Abstract.] 84th annual meeting of the Endocrine Society. June 2002.

Bupropion. RXList.com. www.rxlist.com/frame/display.cgi?drug=Wellbutrin.

Cabot S. The Liver Cleansing Diet. SCB International; 1996.

Carney DE, Tweddell ED. “Double blind evaluation of long acting diethylpropion hydrochloride in obese patients from a general practice.” Medical Journal Australia. 1975; 1(1): 13–15.

Cass H, Holford P. Natural Highs. Avery; 2002.

Chapman AE et al. “Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review.” Surgery. March 2004; 135(3): 326–351.

Chiellini C et al. “Study of the effects of transoral gastroplasty on insulin sensitivity and secretion in obese subjects.” Nutr Metab Cardiovasc Dis. March 2010; 20(3): 202–207.

Chikunguwo S et al. “Influence of obesity and surgical weight loss on thyroid hormone levels.” Surg Obes Relat Dis. November–December 2007; 3(6): 631–635.

Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. National Institutes of Health; National Heart, Lung, and Blood Institute; and National Institute of Diabetes, and Digestive and Kidney Diseases. NIH Publication Number 98-4083. September 1998. www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.htm.

Closset J et al. “Laparoscopic gastric bypass as a revision procedure after transoral gastroplasty.” Obes Surg. December 10, 2009.

Cohen P. Understanding insulin signaling. July 12, 2000. www.wellcome.ac.uk/en/1/awtpubnwswlkbcksp3inssig.html.

Committee for Proprietary Medicinal Products. Opinion: following an Article 31 referral: sibutramine. European Agency for the Evaluation of Medicinal Products Postauthorization Evaluation of Medicines for Human Use. December 2, 2002. www.emea.eu.int/pdfs/human/referral/451402en.pdf.

Complications of obesity. WebMD. 2003. www.medscape.com/viewarticle/457926_10.

Coté GA et al. “Emerging technology: endoluminal treatment of obesity.” Gastrointest Endosc. November 2009; 70(5): 991–999.

Craddock D. “Anorectic drugs: use in general practice.” Drugs. 1976; 11(5): 378–393.

Croft H et al. “Effect on body weight of bupropion sustained-release in patients with major depression treated for 52 weeks.” Clinical Therapy. April 2002; 24(4): 662–672.

Crook WG, Cass H. The Yeast Connection and Women’s Health. Professional Books; 2003.

Crook WG. The Yeast Connection: A Medical Breakthrough. Vintage; 1986.

Csendes A et al. “Management of leaks after laparoscopic sleeve gastrectomy in patients with obesity.” Gastrointest Surg. June 22, 2010.

Cummings DE et al. “Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.” New England Journal of Medicine. 2002; 346(21): 1,623–1,630.

Dargent J. “Laparoscopic adjustable gastric banding: lessons from the first 500 patients in a single institution.” Obesity Surgery. 1999; 5: 446–452.

Degen L, Oesch S, Casanova M, Graf S, Ketterer S, Drewe J, Beglinger C. “Effect of PYY3-36 on food intake in humans.” Gastroenterology. 2005; 129: 1,430.

Devière J et al. “Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter study.” Surg Endosc. March 2008; 22(3): 589–598. Epub November 1, 2007.

Diethylpropion. RXlist.com. www.rxlist.com/frame/display.cgi?drug=TENUATE.

Drezgic M et al. “Should we look for metabolic syndrome (MSy) in subclinical hypothyroidism?” Endocrine Abstracts. 2008; 16: 787.

Erasmus U. Fats That Heal, Fats That Kill. Alive Books; 1999.

European Agency for the Evaluation of Medicinal Products. [Press release.] September 9, 1999. www.emea.eu.int/pdfs/human/press/pr/232599en.pdf.

Ezrin C. Your Fat Can Make You Thin. Contemporary Books; 2001.

Fat cell hormone promotes type 2 diabetes. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. January 2001. www.niddk.nih.gov/welcome/releases/1-01.htm.

Fazylov R et al. “Laparoscopic Roux-en-Y gastric bypass surgery on morbidly obese patients with hypothyroidism.” Obes Surg. June 2008; 18(6): 644–647.

Fen-Phen online information resource. James F. Early, LLC. 2001.

Fife B. The Healing Miracles of Coconut Oil. Piccadilly Books; 2003.

Forslund, H. et al. “Meal patterns and obesity in Swedish women.” European Journal of Clinical Nutrition. 2002; 56: 740–747.

Fraser WD et al. “Are biochemical tests of thyroid function of any value in monitoring patients receiving thyroxine replacement?” British Medical Journal. September 27, 1986; 293(6550): 808–10.

Freudenrich CC. “How fat cells work.” HowStuffWorks.com. home.howstuffworks.com/fat-cell.htm/printable.

Fung TT, Hu FB, Pereira MA, et al. “Whole-grain intake and the risk of type 2 diabetes: a prospective study in men.” American Journal of Clinical Nutrition. 2002; 76: 535–540.

Fung TT et al. “Low-carbohydrate diets and all-cause and cause-specific mortality: two cohort studies.” Annals of Internal Medicine. 2010; 153(5).

Gadde K. “Long-term study finds antidepressants effective for weight loss in women.” DukeMed News Office. September 11, 2001.

Galletti P-M et al. “Effect of fluorine on the thyroidal iodine metabolism in hyperthyroidism.” Journal of Clinical Endocrinology. 1958; 18: 1,102–1,110.

Gate Pharmaceuticals. Adipex-P (phentermine hydrochloride) product information. November 2000. www.gatepharma.com/Adipex-P/adipexscript.pdf.

Gittleman AL. Eat Fat, Lose Weight. Keats Publishing; 1999.

Gittleman AL. The Fat Flush Plan. McGraw-Hill; 2002.

Gittleman AL. Guess What Came to Dinner? Parasites and Your Health. Avery Penguin Putnam; 2001.

Gittleman AL. Why Am I Always So Tired? HarperSanFrancisco; 1999.

GlaxoSmithKline. Wellbutrin SR (bupropion hydrochloride), prescribing information. October 2002. us.gsk.com/products/assets/us_wellbutrinSR.pdf.

Glazer G. “Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety.” Archives of Internal Medicine. 2001; 161(15): 1,814–1,824.

Gobble RM et al. “Gastric banding as a salvage procedure for patients with weight loss failure after Roux-en-Y gastric bypass.” Surg Endosc. April 2008; 22(4): 1019–1022.

Goglia PL. Turn Up the Heat: Unlock the Fat-Burning Power of Your Metabolism. Viking; 2002.

Goode E. “The heavy cost of chronic stress.” New York Times. December 17, 2002.

Gortmaker S, Must LA, Perrin JM, et al. “Social and economic consequences of overweight in adolescence and young adulthood.” New England Journal of Medicine. 1993; 329: 1,008.

Grayson CE, ed. insulin resistance syndrome. WebMD Health. November 2002.

Grout P. Jumpstart Your Metabolism: How to Lose Weight by Changing the Way You Breathe. Fireside; 1998.

Haines PS et al. “Weekend eating in the United States is linked with greater energy, fat, and alcohol intake.” Obesity Research. 2003; 11: 945–949.

Halford JC et al. “Pharmacological management of appetite expression in obesity.” Nat Rev Endocrinol. May 2010; 6(5): 255–269.

Hanks B, Rooney R. The Physique Transformation Program. www.physiquetransformation.com.

Harrison L. Master Your Metabolism. Sourcebooks; 2003.

Hayashi T et al. “Ellagitannins from Lagerstroemia speciosa as activators of glucose transport in fat cells.” Planta Medica. 2002; 68(2): 173–175.

Indications and side effects. Presentations at American Epilepsy Society 56th Annual Meeting. December 2002.

Insulin resistance and pre-diabetes. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Diabetes Information Clearinghouse. May 2003. www.idd.nih.gov/health/diabetes/pubs/insulinres/index.htm.

“Insulin resistance syndrome.” American Academy of Family Physicians. American Family Physician. March 15, 2001.

Isidro ML et al. “Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy.” Endocrine. 2007; 32(1): 79–82. Epub October 2, 2007.

Jahnke, Roger O. “Oxygen metabolism.” HealthWorld. www.healthy.net/asp/templates/article.asp?PageType=Article&ID=991.

Jonsson S, Hedblad B, Engstrom G et al. “Influence of obesity on cardiovascular risk: twenty-three-year follow-up of 22,025 men from an urban Swedish population.” International Journal of Obesity Related Metabolic Disorders. 2002; 26: 1,046.

Judy WV et al. “Antidiabetic activity of a standardized extract (glucosol) from Lagerstroemia speciosa leaves in type II diabetics. A dose-dependence study.” Journal of Ethnopharmacology. 2003; 87(1): 115–117.

Kakuda T, Sakane I, Takihara T, Ozaki Y, Takeuchi H, Kuroyanagi M. “Hypoglycemic effect of extracts from Lagerstroemia speciosa L. Leaves in genetically diabetic KK-AY mice.” Bioscience, Biotechnology and Biochemistry. 1996; 60(2): 204–208.

Kalfarentzos F et al. “Weight loss following vertical banded gastroplasty: intermediate results of a prospective study.” Obesity Surgery. 2001; 11(3): 265–270.

Kasza J et al. “Analysis of poor outcomes after laparoscopic adjustable gastric banding.” Surg Endosc. June 30, 2010.

Kennett GA et al. “New approaches to the pharmacological treatment of obesity: Can they break through the efficacy barrier? ” Pharmacol Biochem Behav. August 3, 2010.

Khan B et al. “Hypogylcemic activity of aqueous extract of some indigenous plants.” Pak J Pharm Sci. 2005; 18(1): 62–64.

Khan MS et al. “Cinnamon improves glucose and lipids of people with type 2 diabetes.” Diabetes Care. 2003; 26: 3,215–3,218.

Knudsen N et al. “Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population.” J Clin Endocrinol Metab. May 3, 2005.

Kolata G. “The fat epidemic/new clues from the lab/how the body knows when to gain or lose.” New York Times. October 17, 2000.

Krotkiewski M. “Thyroid hormones in the pathogenesis and treatment of obesity.” European Journal of Pharmacology. 2002; 440(2–3): 85–98.

Lakka HM, Laaksonen DE, Lakka TA et al. “The metabolic syndrome and cardiovascular disease mortality in middle-aged men.” Journal of the American Medical Association. 2002; 288: 2,709.

Lanc, James et al. “Caffeine affects cardiovascular and neuroendocrinology activation at work and home.” Psychosomatic Medicine 2002; 64: 593–603.

Langer S, Scheer JF. Solved: The Riddle of Illness. Healing Arts Press; 1989.

Lanthaler M et al. “Long term results and complications following adjustable gastric banding.” Obes Surg. May 23, 2010.

Layton, Julia. “How calories work.” HowStuffWorks.com. home.howstuffworks.com/calorie.htm/printable.

Leeds AR. “Glycemic index and heart disease.” American Journal of Clinical Nutrition 2002; 76: 286S–289S.

Lejeune M. “Additional protein intake limits weight gain after weight loss in humans. Abstract t4:02.” Proceedings of the European Congress of Obesity. Helsinki, Finland. June 2003.

Linde, JA et. al. “Self weighing in weight gain prevention and weight loss trials.” Annals of Behavioral Medicine, 2005. December; 30(3): 210–216.

Linquette A, Fossati P. “Hunger control with benzphetamine hydrochloride in the treatment of obesity.” Lille Medical. 1971; 16(suppl 2): 620–624.

Liu F, Kim J, Li Y, Liu X, Li J, Chen X. “An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells.” Journal of Nutrition. 2001; 131(9): 2,242–2,247.

Liu S, Willett WC, Stampfer MJ, Hu FB et al. “A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in U.S. women.” American Journal of Clinical Nutrition.” 2000; 71: 1,455–1,461.

MacGregor A, ed. “The story of surgery for obesity.” American Society of Bariatric Surgeons (ASBS). 2002 Amendment.

Maeda H et al. “Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues.” Biochem Biophys Res Commun. 2005; 332(2): 392–397.

Manson JE, Willett WC, Stampfer MJ, et al. “Body weight and mortality among women.” New England Journal of Medicine. 1995; 333: 677.

Mason EE. “Vertical banded gastroplasty for obesity.” Archives of Surgery. 1982; 117(5): 701–706.

Mason EE. “Why the operation I prefer is vertical banded gastroplasty.” Obesity Surgery. 1991; 1(2): 181–183.

Mason EE et al. “Gastric bypass for obesity after ten years experience.” International Journal of Obesity. 1978; v2(2): v197–206.

Mason EE, Ito C. “Gastric bypass in obesity.” Surgical Clinics of North America. 1967; 47(6): 1,345–1,351.

Mazansky H. “A review of obesity and its management in 263 cases.” South African Medical Journal. 1975; 49(47): 1,955–1,962.

“Medical encyclopedia: obesity.” MEDLINEplus. May 17, 2002. www.nlm.nih.gov/medlineplus/ency/article/003101.htm#Definition.

Meigs JB. “The metabolic syndrome.” British Medical Journal. 2003; 327: 61–62.

Mellin L. The Solution: 6 Winning Ways to Permanent Weight Loss. Regan Books; 1997.

Mercola J, Levy AR. The No-Grain Diet: Conquer Carbohydrate Addiction and Stay Slim for Life. E.P. Dutton; 2003.

Michaud E. “Healing with your sixth sense.” Prevention. May 2003.

Miller PM. The Hilton Head Metabolism Diet. Warner Books; 1983.

Mogul H et al. “The endocrinopathy of obesity: correlate, consequence or cause?” [Abstract.] 84th annual meeting of the Endocrine Society. June 2002.

Mohos E et al. “Quality of life parameters, weight change and improvement of co-morbidities after laparoscopic Roux Y gastric bypass and laparoscopic gastric sleeve resection comparative study.” Obes Surg. July 14, 2010.

Mokdad AH, Ford ES, Bowman BA, et al. “Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.” Journal of the American Medical Association. 2003; 289: 76.

Moreno C et al. “Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study.” Endoscopy. 2008; 40(5): 406–413.

Moulin de Moraes CM et al. “Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass.” Obes Surg. 2005; 15(9): 1,287–1,291.

Muller FO et al. “Availability of phendimetrazine from sustained and non-sustained action formula.” South African Medical Journal. 1975; 49(5): 135–139.

Murakami C, Myoga K, Kasai R, Ohtani K, Kurokawa T, Ishibashi S, Dayrit F, Padolina WG, Yamasaki K. “Screening of plant constituents for effect on glucose transport activity in ehrlich ascites tumour cells.” Chemical and Pharmaceutical Bulletin (Tokyo). 1993; 41(12): 2,129–2,131.

Must A, Spadano J, Coakley EH. “The disease burden associated with overweight and obesity.” Journal of the American Medical Association. 1999; 282: 1,523.

Nannipieri M et al. “Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss.” Int J Obes (Lond). September 2009; 33(9): 1,001 6. Epub July 28, 2009.

Nannipieri M et al. “Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss.” Int J Obes (Lond). September 2009; 33(9): 1,001–1,006.

Nathan PJ et al. “Neuropsychiatric adverse effects of centrally acting antiobesity drugs.” CNS Neurosci Ther. July 7, 2010.

Ngondi Jet al. “IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation.” Lipids in Health and Disease. 2009; 8: 7.

Nguyen NT et al. “The relationship between hospital volume and outcome in bariatric surgery at academic medical centers.” Ann Surg. 2004; 240(4): 586–593, 594.

Nygaard B et al. “Effect of combination therapy with thyroxine (T4) and 3,5,3’-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study.” European Journal of Endocrinology. 2009; 161(6): 895–902.

O’Brien PE et al. “Prospective study of a laparoscopically placed, adjustablic gastric band in the treatment of morbid obesity.” British Journal of Surgery. 1999; 86(1): 113–118.

“One-year prophylactic treatment of euthyroid Hashimoto’s thyroiditis patients with levothyroxine: is there a benefit?” Thyroid. 2001; 11(3): 249–255.

Orlistat. RXList.com. www.rxlist.com/frame/display.cgi?drug=Xenical.

Osono Y, Hirose N, Nakajima K, Hata Y. “The effects of pantethine on fatty liver and fat distribution.” Journal of Atherosclerosis and Thrombosis. 2000; 7(1): 55–58.

Overweight and obesity, defining overweight and obesity. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Nutrition and Physical Activity. April 22, 2003. www.cdc.gov/nccdphp/dnpa/obesity/defining.htm.

Palkhivala A. “New hormone might explain link between diabetes and obesity.” WebMD Health. January 17, 2001.

Parsons WB. “Controlled-release diethylpropion hydrochloride used in a program for weight reduction.” Clinical Therapy. 1981; 3(5): 329–335.

Patel SR, Malhotra A, White DP, Gottlieb DJ, Hu FB. “Association between reduced sleep and weight gain in women.” Am J Epidemiol. November 15, 2006; 164(10): 947–954.

Patel S et al. “Reasons and outcomes of laparoscopic revisional surgery after laparoscopic adjustable gastric banding for morbid obesity.” Surg Obes Relat Dis. 2010; 6(4): 391–398.

Peppard PE, Young T, Palta P, et al. “Longitudinal study of moderate weight change and sleep-disordered breathing.” Journal of the American Medical Association. 2000; 284: 3,015.

Perrone, Tony. Dr. Tony Perrone’s Body Fat Breakthru. Regan Books; 1999.

Pharmacia and Upjohn Company. Didrex (benzphetamine hydrochloride) product information. April 2002. www.pfizer.com/download/uspi_didrex.pdf.

Phendimetrazine information. Eon Labs. June 16, 1999. www.phendimetrazine.org/phendimetrazine-information.htm.

Phendimetrazine. RXlist.com. www.rxlist.com/frame/display.cgi?drug=BONTRIL.

Phentermine. RXlist.com. www.rxlist.com/frame/display.cgi?drug=ADIPEX.

Pi-Sunyer FX. “Medical hazards of obesity.” Annals of Internal Medicine. 1993; 19: 655.

Pijl H et al. “Food choice in hyperthyroidism: potential influence of the autonomic nervous system and brain serotonin precursor availability.” Journal of Clinical Endocrinology and Metabolism. 2001; 86(12): 5,848–5,853.

Plauchu M et al. “Trial of benzphetamine in treatment of obesity.” Lyon Medical. 1969; 222(32): 317–321.

Polovina S et al. “The influence of low calorie–high dietary fibres diet on the change of parameters of the metabolic syndrome.” Endocrine Abstracts. 2008; 16: 484.

Prachand VN et al. “Duodenal switch provides superior weight loss in the super obese (BMI [INSERT LESS THAN SIGN] or = 50 kg/m2) compared with gastric bypass.” Ann Surg. 2006; 244(4): 611–619.

Product review: weight loss, slimming, and diabetes-management supplements (chromium, cla, and pyruvate). ConsumerLab.com.

Purnell JQ. “What’s new in medicine? Obesity.” Professional Publishing, 2003.

Rathi MS et al. “Weight gain during the treatment of thyrotoxicosis using conventional thyrostatic treatment.” J Endocrinol Invest. 2008; 31(6): 505–508.

Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2000.

Richards B. Mastering Leptin. Wellness Resources; 2003.

Rimm EB, Stampfer MF, Giovannucci E, et al. “Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men.” American Journal of Epidemiology. 1995; 141: 1117.

Roos A et al. “Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects.” Journal of Clinical Endocrinology and Metabolism. doi:10.1210/jc.2006-1718.

Ross J. The Diet Cure. Viking Penguin; 1999.

Rubenstein R. “Laparoscopic adjustable gastric banding at a U.S. center with up to 3-year follow-up.” Obesity Surgery. 2002; 12: 380–384.

Samaha F et al. “A low-carbohydrate as compared with a low-fat diet in severe obesity.” New England Journal of Medicine. 2003; 348: 2,074–2,081.

Sanalkumar N et al. “Prevalence and potential implications of undetected thyroid abnormalities in a population of obese patients.” [Abstract.] 84th annual meeting of the Endocrine Society. June 2002.

Sankar R. “Anticonvulsants: newest clinical trials focus on potential indications and side effects.” Medscape Neurology & Neurosurgery. March 5, 2003. www.medscape.org/newarticle/450338.

Scopinaro N, et al. “Biliopancreatic diversion for obesity at eighteen years.” Surgery. 1996; 119(3): 261–268.

Savard M. How to Save Your Own Life: The Savard System for Managing—and Controlling—Your Health Care. Warner Books; 2000.

Savard M. The Savard Health Record: A Six-Step System for Managing Your Health Care. Time Life; 2000.

Schmid S et al. “Sleep loss and metabolic response to breakfast.” Endocrine Abstracts. 2008; 16: 524.

Seeley RR, Stephens TD, Tate P. Anatomy and Physiology. Time Mirror/Mosby College Publishing; 1989.

Shames R, Shames KH. Thyroid Power: Ten Steps to Total Health. Harper Resource; 2001.

Sibutramine. RXlist.com. www.rxlist.com/frame/display.cgi?drug=Meridia.

Simontacchi C. Your Fat Is Not Your Fault. Penguin Putnam; 1998.

Sjorstrom L et al. “Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight gain in obese patients.” Lancet. 1998; 352(9,123): 167–173.

Slotman GJ. “Non transectional open gastric bypass as the definitive bariatric procedure for 61 patients with BMI of 70 and higher.” Obes Surg. 2010; 20(1): 7–12.

Smith S. “Pramlintide treatment reduces 24-hour caloric intake and meal sizes, and improves control of eating in obese subjects: a 6-week translational research study.” Am J Physiol Endocrinol Metab. May 15, 2007.

Sohle J et al. “White tea extract induces lipolytic activity and inhibits adipogenesis in human subcutaneous (pre)-adipocytes.” Nutrition and Metabolism. 2009; 6: 20.

Sonka J et al. “Effects of diet, exercise and anorexigenic drugs on serum thyroid hormones.” Endokrinologie. 1980; 76(3): 351–356.

Spiegel K, Leproult R, Van Cauter E. “Impact of sleep debt on metabolic and endocrine function.” Lancet. 1999; 354: 1,435–1,439.

St-Onge MP. “Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity.” Journal of Nutrition. 2002; 132(3): 329–332.

Stein MR et al. “Ineffectiveness of human chorionic gonadotropin in weight reduction: a double-blind study.” American Journal of Clinical Nutrition. 1976; 29: 940–948.

Strauss RS. “Childhood obesity and self-esteem.” Pediatrics. 2000; 105: e15.

Suter M et al. “Band erosion after laparoscopic gastric banding: occurrence and results after conversion to Roux en Y gastric bypass.” Obes Surg. 2004; 14(3): 381–386.

Suter M et al. “A 10 year experience with laparoscopic gastric banding for morbid obesity: high long term complication and failure rates.” Obes Surg. 2006; 16(7): 829–835.

Suzuki Y, Unno T, Ushitani M, Hayashi K, Kakuda T. “Antiobesity activity of extracts from Lagerstroemia speciosa L. leaves on female KK-Ay mice.” Journal of Nutritional Science and Vitaminology (Tokyo). 1999; 45(6): 791–795.

Swithers SE. “A role for sweet taste: calorie predictive relations in energy regulation by rats.” Behavioral Neuroscience. 2008; 122(1): 161–173.

Taubes G. “What if it’s all been a big fat lie?” New York Times. July 2, 2002.

Teitelbaum J. From Fatigued to Fantastic. Avery Penguin Putnam; 2001.

Telles S, Nagarathna R, Nagendra HR. “Breathing through a particular nostril can alter metabolism and autonomic activities.” Indian J Physiol Pharmacol. 1994; 38(2): 133.

Tevaarwerk G. “Thyroid hormone replacement using a combination of levothyroxine plus slow-release liothyronine: beyond proof of principle.” Endocrine Abstracts. 2008; 16: 771.

Tice JA et al. “Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures.” Am J Med. 2008; 121(10): 885–893.

Triantafyllidis G et al. “Anatomy and complications following laparoscopic sleeve gastrectomy: radiological evaluation and imaging pitfalls.” Obes Surg. July 24, 2010.

Tsesmeli N et al. “The future of bariatrics: endoscopy, endoluminal surgery, and natural orifice transluminal endoscopic surgery.” Endoscopy. February 2010; 42(2): 155–162.

Val-Laillet D et al. “Chronic vagus nerve stimulation decreased weight gain, food consumption and sweet craving in adult obese minipigs.” Appetite. June 19, 2010.

Valle-Jones JC et al. “A comparative study of phentermine and diethylpropion in the treatment of obese patients in general practices.” Pharmatherapeutica. 1983; 3(5): 300–304.

Van Cauter E, Leproult R, Plat L. “Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men.” Journal of the American Medical Association. 2000; 284: 861–868.

Vigersky RA et al. “Thyrotropin suppression by metformin.” J Clin Endocrinol Metab. 2006; 91(1): 225–227.

Volkova A et al. “Thyroid function is associated with insulin sensibility.” Endocrine Abstracts. 2008; 16: 779.

Wadden TA et al. “Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD Trial.” Obesity (Silver Spring). June 17, 2010.

Weiner R et al. “Outcome after laparoscopic adjustable gastric banding 8 years experience.” Frankfurt Center for Minimally Invasive Surgery, Section of Bariatric Surgery, Germany. rweiner@khs ffm.de.

Weintraub M et al. “A double-blind clinical trial in weight control: use of fenfluramine and phentermine alone and in combination.” Archives of Internal Medicine. 1984; 144(6): 1,143–1,148.

Willett W, Manson J, Liu S. “Glycemic index, glycemic load, and risk of type 2 diabetes.” American Journal of Clinical Nutrition. 2002; 76(suppl): 274S–280S.

Wittgrove AC, Clark GW. “Laparoscopic gastric bypass, Roux-en-Y—500 patients. Technique and results with 3–60 month follow-up.” Obesity Surgery. 2000; 10: 233–239.

Wolcott WL, Fahey T. The Metabolic Typing Diet: Customize Your Diet to Your Own Unique Body Chemistry. Broadway Books; 2002.

Wolever TM, Mehling C. “High-carbohydrate-low-glycaemic index dietary advice improves glucose disposition index in subjects with impaired glucose tolerance.” British Journal of Nutrition. 2002; 87: 477–487.

Wolf AM, Colditz GA. “Current estimates of the economic cost of obesity in the United States.” Obesity Research. 1998; 6: 97.

Zieba R. “Obesity: a review of currently used antiobesity drugs and new compounds in clinical development.” [Polish]. Postepy Hig Med Dosw. 2007; 61: 612–626.

Ziomber A et al. “Magnetically induced vagus nerve stimulation and feeding behavior in rats.” J Physiol Pharmacol. September 2009; 60(3): 71–77.